A detailed investigation of the IAPP peptide domains that are critical for self-aggregation, interaction with Aβ, AMY receptor subtypes and their ability to reduce oligomer mediated cell death, will therefore be important for designing improved mimetics and IAPP based treatment strategies for the management of AD and T2D. This evidence concerns the gene IAPP and Alzheimer disease.